LYMECYCLINE

LYMECYCLINE

Get in touch with us!












      I accept conditions of use and privacy policy of this website.

    I want to receive updated information on the latest news.

    An overview

    Limecycline is an antibiotic with bacteriostatic action that acts by inhibiting protein synthesis. It has a broad spectrum against Gram-positive and Gram-negative germs, especially Rickettsiae, Mycoplasma pneumoniae, Chlamydia sp, Vibrio Cholerae, Bacteroides sp, Brucella sp, etc. It is used in the treatment of:

    • Otolaryngological and dental infections.
    • Respiratory infections
    • Urethritis (non-gonococcal)
    • Gastrointestinal infections

    • Genitourinary infections
    • Skin and soft-tissue infections
    • Brucellosis (associated with streptomycin)
    • Typhoid typhus, psittacosis.

    • Product Type: Tetracycline Antibiotic
    • CAS Number: 992-21-2
    • Common Indications: Treatment of moderate to severe acne
    • Product Status: Commercial
    • Available Grades: Non-Micronized
    • Documentation: CEP, CoA, MSDS
    Lymecycline f

    Advantages

    Efficacy:

    • Bacteriostatic action over a wide range of bacteria.

    • Good safety profile and well tolerated.

    • Optimal cost-efficiency across Europe..

    Safety:

    • Rapidly and completely absorbed in the 
gastrointestinal tract.

    • Parenterally well-absorbed.

    Finished
    Dosage forms

    Oral:

    Capsule:
    250 and 500 mg.

    Global Market status

    0 M

    USD global market sales in 2021

    0 MT

    consumed globally

    0 %

    Lorem ipsum solor

    Few API manufacturers to cover worldwide demand.

    Our API

    Lymecycline

    • Our API Limecycline is manufacture in accordance with cGMP and stringent international quality standards.

    Quality

    • Our quality control follows every stage from development of analytical methods to the control of manufacturing process.

    Samples availables

    destacado
    MINOCYCLINE

    PATENT PROTECTION

    Logo OFF

    Contact us & obtain the technical sheet












        I accept conditions of use and privacy policy of this website.

      I want to receive updated information on the latest news.

      Suanfarma